Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples